# A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function

> **NCT05727644** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 42 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis (NASH)

## Interventions

- **DRUG:** NNC0194-0499

## Key facts

- **NCT ID:** NCT05727644
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-15
- **Primary completion:** 2023-11-10
- **Final completion:** 2023-11-10
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727644, "A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05727644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*